Beecken Petty O'Keefe & Company
Description
Beecken Petty O'Keefe & Company (BPOC) is a Chicago-based private equity firm with an exclusive focus on the healthcare industry. Established in 1996, BPOC has built a strong reputation for partnering with middle-market healthcare companies, providing capital for buyouts, recapitalizations, and growth equity investments. Their deep sector expertise allows them to identify and support businesses across various healthcare sub-sectors, including provider services, payor services, healthcare IT, and medical products and devices.
BPOC's investment strategy centers on identifying established, profitable companies with strong management teams and significant growth potential within the fragmented healthcare market. They typically target companies with enterprise values ranging from $50 million to $500 million. The firm aims to be a value-add partner, leveraging its extensive network and operational experience to help portfolio companies scale, optimize operations, and pursue strategic initiatives. Their long-term approach emphasizes building sustainable value through organic growth and strategic acquisitions.
With substantial capital under management, BPOC has demonstrated significant financial capacity to execute its investment strategy. For instance, the firm successfully closed its sixth fund, BPOC Fund VI, at $780 million in 2023, following its $550 million predecessor fund (BPOC Fund V) in 2018. This capital enables BPOC to make equity investments that typically range from $20 million to over $100 million, allowing them to take meaningful, often controlling, stakes in their portfolio companies. Their consistent fundraising success underscores investor confidence in their specialized healthcare investment model and track record.
Investor Profile
Beecken Petty O'Keefe & Company has backed more than 45 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 18% of its total and boasts 26 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Private Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, Finland.
- Strong thematic focus on Health Care, Medical, Pharmaceutical.
- Typical check size: $20M – $150M.
Stage Focus
- Series Unknown (67%)
- Private Equity (16%)
- Series B (9%)
- Debt Financing (4%)
- Seed (2%)
- Series A (2%)
Country Focus
- United States (89%)
- Finland (2%)
Industry Focus
- Health Care
- Medical
- Pharmaceutical
- Software
- Information Technology
- Medical Device
- Wellness
- Hospital
- Biotechnology
- Consulting
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
